Haematologica (Mar 2024)
Efficacy and safety of daratumumab plus bortezomib and dexamethasone in newly diagnosed Mayo 2004 stage IIIA or IIIB light-chain amyloidosis: a prospective phase II study
Abstract
Not available.
Haematologica (Mar 2024)
Not available.